Skip to main content
. 2015 Nov 20;112(47):803–808. doi: 10.3238/arztebl.2015.0803

Table. Evaluation of indirect comparisons and network meta-analyses in data examples.

Checklist item Baker and Phung (4) Alfivirec et al. (5)
1. Questions established in advance? graphic file with name Dtsch_Arztebl_Int-112-0803_003.jpg graphic file with name Dtsch_Arztebl_Int-112-0803_003.jpg
2. Rationale given for use of indirect comparisons? graphic file with name Dtsch_Arztebl_Int-112-0803_003.jpg graphic file with name Dtsch_Arztebl_Int-112-0803_003.jpg
3. Rationale given for choice of common comparators? *1 graphic file with name Dtsch_Arztebl_Int-112-0803_003.jpg
4. Search of literature complete? (graphic file with name Dtsch_Arztebl_Int-112-0803_003.jpg) *2 (graphic file with name Dtsch_Arztebl_Int-112-0803_003.jpg)*5
5. Inclusion and exclusion criteria clearly described? graphic file with name Dtsch_Arztebl_Int-112-0803_003.jpg graphic file with name Dtsch_Arztebl_Int-112-0803_003.jpg
6. Complete report of all data? (graphic file with name Dtsch_Arztebl_Int-112-0803_003.jpg)*3 graphic file with name Dtsch_Arztebl_Int-112-0803_003.jpg
7. Basic assumptions examined? *4 *4
8. Suitable statistical procedures used? graphic file with name Dtsch_Arztebl_Int-112-0803_003.jpg graphic file with name Dtsch_Arztebl_Int-112-0803_003.jpg
9. Limitations described? graphic file with name Dtsch_Arztebl_Int-112-0803_003.jpg graphic file with name Dtsch_Arztebl_Int-112-0803_003.jpg

*1It is unclear whether or not this is a selective choice.

*2There is no list of excluded references.

*3There is no representation of pooled estimates for pairwise comparison of dabigatran and warfarin.

*4Homogeneity has not been sufficiently examined.

*5The method used to search the secondary source is not clearly shown. It is therefore unclear whether the study pool up is up to date and complete.